This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
4,5 Thrombosis is a significant cause of morbidity and mortality in PNH, with patients exhibiting an increased risk of life-threatening thromboembolic events such as stroke, deep vein thrombosis and pulmonary embolism. 6,7 The chronic nature of PNH significantly affects patients quality of life and health outcomes. 9 Brodsky RA et al.
As the market continues to demand specialization in drug distribution and clinicalmanagement of complex therapies, specialty pharmacy continues to evolve. PQA SAMs are members-only events. Speakers from Loma Linda University and Walgreens will discuss their services featured in the guide. Register today!
Indeed, vutrisiran – a new drug for the treatment of amyloidosis – has been found to be effective in reducing mortality, cardiovascular events and markers of disease progression. In light of HELIOS-B trial results , as Professor Esther Gonzalez Lopez commented, for patients with amyloidosis the future is brighter.
Durvalumab is ‘promising step forward’ The latest approval from the MHRA is based on positive data from the AEGEAN Phase III trial in rNSCLC , which showed that durvalumab-based treatment before and after surgery reduced the risk of recurrence, progression events or death by 32% versus neoadjuvant chemotherapy alone.
Did you know that communicative errors are a major contributing factor to hospital sentinel events? In this method, clinical personnel interacts with caregivers formally. The goal is to learn and write down up to five significant non-clinicalmanagement techniques and ideas for individualized care.
Moreover, in a further study, they also showed that a machine learning model, accurately triaged patients undergoing radiotherapy and chemoradiation and was able to direct clinicalmanagement, reducing acute care rates in comparison to standard care. Daily steps AI model and prediction of hospitalisation.
The FDA describes these products under enforcement discretion if they are intended to inform clinicalmanagement for nonserious situations or conditions, help patients self-manage their disease or conditions without providing specific treatment, or automate simple tasks for health care providers. IMDRF SaMD Risk Categorization.
The FDA describes these products under enforcement discretion if they are intended to inform clinicalmanagement for nonserious situations or conditions, help patients self-manage their disease or conditions without providing specific treatment, or automate simple tasks for health care providers. IMDRF SaMD Risk Categorization.
Bhat, head of department – central laboratory and consultant microbiologist and infection control officer at St Martha’s Hospital, Bengaluru, India, showcased her work with ChatGPT in the clinical microbiology laboratory.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content